3 completed, 1 not yet recruiting, 1 unknown. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Not yet recruiting 1, Unknown 1 |
Follow DWP16001: new trials by email Literature Review of DWP16001 trials Research Report on DWP16001
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus DWP16001, DWC202518, Placebo of DWP16001 - T2DM (Type 2 Diabetes Mellitus) | Phase 3 | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | 510 | 2026-06-01 | 2026-06-02 |
| The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin DWP16001, Dapagliflozin, DWP16001 Placebo - Diabetes Mellitus, Diabetes Mellitus, Type 2 | Phase 3 | Unknown | Daewoong Pharmaceutical Co. LTD. | 340 | 2022-09-28 | 2024-04-04 |
| Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin DWP16001 - T2DM (Type 2 Diabetes Mellitus) | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | 159 | 2021-05-25 | 2022-10-25 |
| The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. Dapagliflozin - T2DM (Type 2 Diabetes Mellitus) | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | 200 | 2020-11-18 | 2022-10-25 |
| The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus. DWP16001 - T2DM (Type 2 Diabetes Mellitus) | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | 140 | 2020-11-11 | 2022-10-25 |
Diabetes Mellitus, Type 2 (5) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1)
Daewoong Pharmaceutical Co. LTD. (5)
South Korea (4) · China (1)
Linong Ji, Dr. (1)